Aldemar Montero

1.6k total citations
18 papers, 1.1k citations indexed

About

Aldemar Montero is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Aldemar Montero has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 7 papers in Oncology and 4 papers in Immunology. Recurrent topics in Aldemar Montero's work include Hematopoietic Stem Cell Transplantation (11 papers), Immune Cell Function and Interaction (4 papers) and Acute Myeloid Leukemia Research (3 papers). Aldemar Montero is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Immune Cell Function and Interaction (4 papers) and Acute Myeloid Leukemia Research (3 papers). Aldemar Montero collaborates with scholars based in United States, Malaysia and Japan. Aldemar Montero's co-authors include Bipin N. Savani, Stephan Mielke, Katayoun Rezvani, Roger Kurlander, Yosuke Okada, J. Douglas Coffin, Marja M. Hurley, Thomas Doetschman, Toshitaka Nakamura and Masato Tomita and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Aldemar Montero

17 papers receiving 1.1k citations

Peers

Countries citing papers authored by Aldemar Montero

Since Specialization

Citations

This map shows the geographic impact of Aldemar Montero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldemar Montero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldemar Montero more than expected).

Fields of papers citing papers by Aldemar Montero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aldemar Montero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldemar Montero. The network helps show where Aldemar Montero may publish in the future.

Co-authorship network of co-authors of Aldemar Montero

This figure shows the co-authorship network connecting the top 25 collaborators of Aldemar Montero. A scholar is included among the top collaborators of Aldemar Montero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aldemar Montero. Aldemar Montero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Real-world quality of life (QoL) in black, indigenous and people of color (BIPOC) treated with palbociclib (PAL) and endocrine therapy for hormone receptor–positive (HR+)/human epidermal growth factor receptor 2–negative (HER2–) advanced breast cancer (ABC): A subgroup analysis from POLARIS. 2021 ·Journal of Clinical Oncology ·Gabrielle B. Rocque, Joanne L. Blum, Aldemar Montero, Meghan Karuturi, (unknown), (unknown), Christopher Gallagher, (unknown), Joseph C. Cappelleri, (unknown), Yao Wang, Debu Tripathy	1
2	Abstract PD10-03: Quality of life in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer treated with palbociclib in real-world practice settings 2020 ·Cancer Research ·Gabrielle B. Rocque, Joanne L. Blum, Aldemar Montero, (unknown), Sobha Kurian, Richard C. Frank, (unknown), Mayank Ajmera, David Coblentz, Joseph C. Cappelleri, Yao Wang, Debu Tripathy	3
3	Understanding palbociclib practice patterns in a real-world setting. 2019 ·Journal of Clinical Oncology ·Gabrielle B. Rocque, Joanne L. Blum, Aldemar Montero, Sharon Wilks, D. Mark Anderson, Mohamad A. Salkeni, Sami Diab, (unknown), (unknown), (unknown), Bethany Sleckman, Joseph C. Cappelleri, Yao Wang, Debu Tripathy	1
4	A Pilot Study Of Rituximab In Patients With Moderate Aplastic Anemia, Diamond-Blackfan Anemia and Pure Red Cell Aplasia 2013 ·Blood ·Sabrina Martyr, (unknown), Aldemar Montero, Cynthia E. Dunbar, Elizabeth M. Kang, Phillip Scheinberg, Barbara Weinstein, Xin Tian, Neal S. Young, Adrian Wiestner	2
5	Managing Chronic Myeloid Leukemia: A Coordinated Team Care Perspective 2011 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), (unknown), (unknown), (unknown), (unknown), Morgan L. McLemore, (unknown), Aldemar Montero, (unknown), (unknown), (unknown), (unknown), (unknown), Leonard T. Heffner, Elliott F. Winton, Martha Arellano, H. Jean Khoury	12
6	Absolute Lymphocyte Count on Day 30 Is a Surrogate for Robust Hematopoietic Recovery and Strongly Predicts Outcome after T Cell-Depleted Allogeneic Stem Cell Transplantation 2007 ·Biology of Blood and Marrow Transplantation ·Bipin N. Savani, Stephan Mielke, Katayoun Rezvani, Aldemar Montero, Agnes S. M. Yong, (unknown), (unknown), Roger Kurlander, Anurag K. Singh, Richard Childs, A. John Barrett	96
7	T Cell Depleted Peripheral Blood Stem Cell Allotransplantation with T Cell Add Back for Patients with Hematological Malignancies: Effect of Chronic GVHD on Outcome 2006 ·Biology of Blood and Marrow Transplantation ·Aldemar Montero, Bipin N. Savani, Aarthi Shenoy, Elizabeth J. Read, Charles S. Carter, Susan F. Leitman, Stephan Mielke, Katayoun Rezvani, Richard Childs, A. John Barrett	38
8	Chronic GVHD and Pretransplantation Abnormalities in Pulmonary Function Are the Main Determinants Predicting Worsening Pulmonary Function in Long-term Survivors after Stem Cell Transplantation 2006 ·Biology of Blood and Marrow Transplantation ·Bipin N. Savani, Aldemar Montero, Ramaprasad Srinivasan, Anurag K. Singh, Aarthi Shenoy, Stephan Mielke, Katayoun Rezvani, Shervin Karimpour, Richard Childs, A. John Barrett	43
9	High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT 2006 ·Blood ·Katayoun Rezvani, Stephan Mielke, Mojgan Ahmadzadeh, Yasemin Kilical, Bipin N. Savani, (unknown), Keyvan Keyvanfar, Aldemar Montero, Nancy F. Hensel, Roger Kurlander, A. John Barrett	277
10	Improved Outcome for Peripheral Blood Stem Cell Transplantation for Advanced Primary Myelodysplastic Syndrome 2005 ·Biology of Blood and Marrow Transplantation ·Scott R. Solomon, Bipin N. Savani, Richard Childs, Aldemar Montero, Carol Boss, Elizabeth J. Read, Susan F. Leitman, A. John Barrett	10
11	Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation 2005 ·Biology of Blood and Marrow Transplantation ·Bipin N. Savani, Aldemar Montero, Colin O. Wu, (unknown), Elizabeth J. Read, Cynthia E. Dunbar, Richard Childs, Scott R. Solomon, A. John Barrett	41
12	Lineage‐specific engraftment and outcomes after T‐cell‐depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning 2005 ·British Journal of Haematology ·Aldemar Montero, Bipin N. Savani, Roger Kurlander, Elizabeth J. Read, Susan F. Leitman, Richard Childs, Scott R. Solomon, A. John Barrett	12
13	Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation 2005 ·Blood ·Scott R. Solomon, Stephan Mielke, Bipin N. Savani, Aldemar Montero, Laura Wisch, Richard Childs, Nancy F. Hensel, John Schindler, Victor Gheţie, Susan F. Leitman, (unknown), Charles S. Carter, Roger Kurlander, Elizabeth J. Read, Ellen S. Vitetta, A. John Barrett	109
14	Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia 2005 ·Blood ·Bipin N. Savani, Katayoun Rezvani, Stephan Mielke, Aldemar Montero, Roger Kurlander, Charles S. Carter, Susan F. Leitman, Elizabeth J. Read, Richard Childs, A. John Barrett	70
15	Prediction and Prevention of Transplant Related Mortality from Pulmonary Causes Following Total Body Irradiation and Allogeneic Stem Cell Transplantation. 2004 ·Blood ·Bipin N. Savani, Aldemar Montero, (unknown), (unknown), Richard Childs, Scott R. Solomon, John Barrett	1
16	Improved Outcomes for Peripheral Blood Stem Cell Transplantation in Advanced Myelodysplastic Syndrome. 2004 ·Blood ·Scott R. Solomon, Richard Childs, Aldemar Montero, Elaine M. Sloand, Laura Wisch, Leslie Wehrlen, John Barrett	0
17	Impaired Osteoclast Formation in Bone Marrow Cultures of Fgf2 Null Mice in Response to Parathyroid Hormone 2003 ·Journal of Biological Chemistry ·Yosuke Okada, Aldemar Montero, Xuxia Zhang, Takanori Sobue, Joseph A. Lorenzo, Thomas Doetschman, J. Douglas Coffin, Marja M. Hurley	41
18	Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation 2000 ·Journal of Clinical Investigation ·Aldemar Montero, Yosuke Okada, Masato Tomita, Masako Ito, Hiroshi Tsurukami, Toshitaka Nakamura, Thomas Doetschman, J. Douglas Coffin, Marja M. Hurley	373

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact